美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Global Partners Lp

53.64

+0.49000.92%

盘后：53.640.00000.00%18:11 EDT

成交量：3.81万

成交额：203.34万

市值：18.19亿

市盈率：17.15

高：54.34

开：53.42

低：52.46

收：53.15

数据加载中...

总览公司新闻公告

歌礼制药-B(01672)将在ADA第85届科学会议上以壁报形式报告口服小分子GLP-1R激动剂ASC30及脂肪靶向、减重不减肌候选药物ASC47的研究结果

成都汇阳投资关于CRO 概念+业绩增长

GLP-1赛道竞争白热化：进口主导，国产减重药能否撕开差异化缺口？

21世纪经济报道

Pluri获Alliance Global Partners首次覆盖，给予买入评级, 目标价12.00美元。

【翰森制药授予Regeneron在研GLP-1/GIP双受体激动剂HS-20094海外独占许可】翰森制药宣布与Regeneron Pharmaceuticals, Inc.订立许可协议*，授予Regeneron开发、生产及商业化HS-20094的全球独占许可。根据协议，翰森制药将获得8,000万美元首付款，并有资格根据该产品开发、注册审批和商业化进展收取最高19.3亿美元里程碑付款，以及未来潜在产品销售的双位数百分比特许权使用费。

国内GLP-1创新减重药物研究首登国际顶刊今年有望与“同门”替尔泊肽在中国市场“同台竞技”

每日经济新闻

GLP-1之后，诺和诺德的“诺亚方舟”在哪里？

国内GLP-1创新减重药研究首次登上国际顶刊，有望年内获批上市

荣耀登顶 | 全球首款申报上市的GCG/GLP-1双受体激动减重降糖药物玛仕度肽的临床研究结果在《新英格兰医学杂志》发布

【众生药业：子公司一类创新药RAY1225注射液两项降糖III期临床试验获伦理批件】众生药业5月25日晚间公告，公司控股子公司广东众生睿创生物科技有限公司自主研发的一类创新多肽药物RAY1225注射液用于2型糖尿病患者的两项III期临床试验获得组长单位北京大学人民医院伦理审查批件，批准项目开展。RAY1225注射液是具有全球自主知识产权的创新结构多肽药物，具有GLP-1受体和GIP受体双重激动活性。

GLP-1赛道生变：礼来反超，诺和诺德换帅，口服药豪赌胜算几何？

医药：礼来25Q1收入增长强劲，关注GLP-1药物数据读出

诺和诺德CEO将卸任，成也GLP-1，败也GLP-1！

医药行业研究：礼来25Q1收入增长强劲关注GLP-1药物数据读出

太平洋证券股份...

Global Partners2025财年第一财季实现净利润14.27百万美元，同比增加263.27%

甘李药业：GZR102注射液Ⅰ期临床试验完成首例受试者给药

港股异动 | 来凯医药-B(02105)午后涨超4% 降脂增肌为下一代GLP-1竞争重点 LAE102受市场关注

翰宇药业：与碳云智肽签署《GLP-1R/GIPR/GCGR三重激动剂多肽创新药物联合开发协议》

替尔泊肽“头对头”完胜司美格鲁肽千亿GLP-1市场迎“双寡头”时代

21世纪经济报道

美国最大PBM“站队”诺和诺德，礼来大跌10%，GLP-1“双姝”价格战开打！

华尔街见闻

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/GLP/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GLP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLP\",,,,,undefined,":{"symbol":"GLP","market":"US","secType":"STK","nameCN":"Global Partners Lp","latestPrice":53.64,"timestamp":1749240000000,"preClose":53.15,"halted":0,"volume":38088,"hourTrading":{"tag":"盘后","latestPrice":53.64,"preClose":53.64,"latestTime":"18:11 EDT","volume":5435,"amount":291531.62,"timestamp":1749247904088},"delay":0,"floatShares":27137973,"shares":33904637,"eps":3.127877,"marketStatus":"休市中","change":0.49,"latestTime":"06-06 16:00:00 EDT","open":53.42,"high":54.34,"low":52.4632,"amount":2033375.1852960002,"amplitude":0.035311,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.127877,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1127966400000,"exchange":"NYSE","adjPreClose":53.15,"dividendRate":0.054717,"preHourTrading":{"tag":"盘前","latestPrice":51.86,"preClose":53.015,"latestTime":"09:08 EDT","volume":1,"amount":51.86,"timestamp":1749215308577},"postHourTrading":{"tag":"盘后","latestPrice":53.64,"preClose":53.64,"latestTime":"18:11 EDT","volume":5435,"amount":291531.62,"timestamp":1749247904088},"volumeRatio":0.726315791966759,"impliedVol":0.225,"impliedVolPercentile":0.136},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLP\",,,,,undefined,":{"symbol":"GLP","floatShares":27137973,"roa":"4.67%","roe":"18.09%","lyrEps":2.44604,"volumeRatio":0.726315791966759,"shares":33904637,"dividePrice":2.935,"high":54.34,"amplitude":0.035311,"preClose":53.15,"low":52.4632,"week52Low":37.0034,"pbRate":"2.93","psRate":"0.10","week52High":60,"institutionHeld":0.4838,"latestPrice":53.64,"eps":3.127877,"divideRate":0.054717,"volume":38088,"delay":0,"ttmEps":3.127877,"open":53.42,"prevYearClose":46.55,"prevWeekClose":52.52,"prevMonthClose":52.52,"prevQuarterClose":53.38,"fiveDayClose":52.52,"twentyDayClose":48.05,"sixtyDayClose":53.95},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLP\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2542827886","title":"歌礼制药-B(01672)将在ADA第85届科学会议上以壁报形式报告口服小分子GLP-1R激动剂ASC30及脂肪靶向、减重不减肌候选药物ASC47的研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2542827886","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542827886?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 08:09","pubTimestamp":1749427785,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B 发布公告，公司董事会宣布将在美国芝加哥举行的美国糖尿病协会第85届科学会议上以壁报形式报告口服小分子GLP-1受体激动剂 ASC30以及脂肪靶向、减重不减肌候选药物ASC47的早期研究数据。ADA已成为全球糖尿病领域最具影响力的非营利组织之一。其年度科学会议被视为行业风向标，展示前沿临床实践与研究方向。ADA第85届科学会议将于今年6月20至23日在美国芝加哥举行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1302675.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","GLP","BK1515","BK4590","BK1191","01672","01477","BK1161","BK4144"],"gpt_icon":0},{"id":"2541793380","title":"成都汇阳投资关于CRO 概念+业绩增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2541793380","media":"鲁网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541793380?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 21:36","pubTimestamp":1749130560,"startTime":"0","endTime":"0","summary":"中国CRO市场在全球市场中的占比逐渐提高，已然成为全球CRO行业增长的关键驱动力之一。百花医药（维权）热点题材：CRO概念+创新药+细胞免疫治疗业绩表现：2025年Q1营收9692万元，同比增长6.65%，净利润2072万元，净利润同比增长0.28%核心优势：专注中药CRO+特色化药CDMO，受益于中药创新药政策红利。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-06-05/doc-ineyzwyx8080718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002821","LU1328615791.USD","BK0216","603127","LU1969619763.USD","BK0102","300759","GLP","BK4590","LU2328871848.SGD","LU1997245094.SGD","BK0077","LU1997244956.HKD","300149","BK0239","600721","BK0132","BK1574","BK4144","BK0028","LU0456842615.SGD","300363","LU2495084118.USD","LU1997245177.USD","06978","BK1161","603259","688202","LU2488822045.USD"],"gpt_icon":0},{"id":"2540772332","title":"GLP-1赛道竞争白热化：进口主导，国产减重药能否撕开差异化缺口？","url":"https://stock-news.laohu8.com/highlight/detail?id=2540772332","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540772332?lang=zh_cn&edition=fundamental","pubTime":"2025-06-03 15:52","pubTimestamp":1748937170,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者闫硕北京报道GLP-1类减重药物领域又传来重磅消息。6月2日，翰森制药宣布与RegeneronPharmaceuticals,Inc.订立许可协议，授予Regeneron开发、生产及商业化HS-20094的全球独占许可（不含中国内地、香港及澳门）。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202506033420618478.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202506033420618478.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4590","BK4144","GLP"],"gpt_icon":0},{"id":"2540612799","title":"Pluri获Alliance Global Partners首次覆盖，给予买入评级, 目标价12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2540612799","media":"金融界","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540612799?lang=zh_cn&edition=fundamental","pubTime":"2025-06-02 22:25","pubTimestamp":1748874319,"startTime":"0","endTime":"0","summary":"Pluri(PLUR.US)获Alliance Global Partners首次覆盖，给予买入评级, 目标价12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602222654950b9ef4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602222654950b9ef4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLUR","GLP"],"gpt_icon":0},{"id":"2540573760","title":"【翰森制药授予Regeneron在研GLP-1/GIP双受体激动剂HS-20094海外独占许可】 翰森制药宣布与Regeneron Pharmaceuticals, Inc.订立许可协议*，授予Regeneron开发、生产及商业化HS-20094的全球独占许可。根据协议，翰森制药将获得8,000万美元首付款，并有资格根据该产品开发、注册审批和商业化进展收取最高19.3亿美元里程碑付款，以及未来潜在产品销售的双位数百分比特许权使用费。","url":"https://stock-news.laohu8.com/highlight/detail?id=2540573760","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540573760?lang=zh_cn&edition=fundamental","pubTime":"2025-06-02 19:37","pubTimestamp":1748864273,"startTime":"0","endTime":"0","summary":"翰森制药宣布与Regeneron Pharmaceuticals, Inc.订立许可协议*，授予Regeneron开发、生产及商业化HS-20094的全球独占许可。根据协议，翰森制药将获得8,000万美元首付款，并有资格根据该产品开发、注册审批和商业化进展收取最高19.3亿美元里程碑付款，以及未来潜在产品销售的双位数百分比特许权使用费。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/02193750811486.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["03692","BK1191","BK1589","BK4590","GLP","BK4144","BK1583"],"gpt_icon":0},{"id":"2539241247","title":"国内GLP-1创新减重药物研究首登国际顶刊 今年有望与“同门”替尔泊肽在中国市场“同台竞技”","url":"https://stock-news.laohu8.com/highlight/detail?id=2539241247","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539241247?lang=zh_cn&edition=fundamental","pubTime":"2025-05-30 16:37","pubTimestamp":1748594250,"startTime":"0","endTime":"0","summary":"近日，国内GLP-1类创新减重药物玛仕度肽在中国超重或肥胖受试者中的Ⅲ期临床研究（GLORY-1）登上国际知名期刊《新英格兰医学杂志》，这是全球首个且唯一申报上市的胰高血糖素（GCG）/胰高血糖素样肽-1（GLP-1）双受体激动剂减重降糖药物的临床研究首次登上医学权威学术期刊。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202505303419167220.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505303419167220.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["YINN","BK4585","BK4588","BK4590","BK4614","BK4144","GLP"],"gpt_icon":0},{"id":"2538719487","title":"GLP-1之后，诺和诺德的“诺亚方舟”在哪里？","url":"https://stock-news.laohu8.com/highlight/detail?id=2538719487","media":"药时代","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538719487?lang=zh_cn&edition=fundamental","pubTime":"2025-05-27 08:05","pubTimestamp":1748304331,"startTime":"0","endTime":"0","summary":"如何摆脱“GLP-1依赖症”，是当下诺和诺德需要回答的问题。信达生物GLP-1R/GCGR双靶点药物玛仕度肽已提交上市申请，恒瑞医药、博瑞医药等15家企业的仿制药进入III期临床，九源基因的“吉优泰”成为首个申报上市的司美格鲁肽生物类似药。FDA也已于近日正式受理诺和诺德口服版减肥药Wegovy的新药申请，用于慢性体重管理。根据诺和诺德发布的公告，FDA预计将于今年第四季度公布审批结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527094955a48d9c06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527094955a48d9c06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ1G4Q59.USD","GLP","NVO","BK4599","LU1093756168.USD","BK4585","IE00BKVL7J92.USD","BK4532","LU1093756325.SGD","BK4007","BK4144","BK4588","LU0154236417.USD","BK4590"],"gpt_icon":1},{"id":"2538246120","title":"国内GLP-1创新减重药研究首次登上国际顶刊，有望年内获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2538246120","media":"第一财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538246120?lang=zh_cn&edition=fundamental","pubTime":"2025-05-26 15:35","pubTimestamp":1748244912,"startTime":"0","endTime":"0","summary":"当地时间5月25日，《新英格兰医学杂志》（NEJM）公布了一项来自中国研究者的GLP-1类减重创新药玛仕度肽的临床研究成果。这也是中国GLP-1类减重药乃至整个代谢和内分泌疾病领域的创新药临床研究成果首次登上国际医学权威期刊。最新公布的研究来自于北京大学人民医院纪立农教授领衔开展的3期、双盲、安慰剂对照试验（GLORY-1）结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202505263414449411.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505263414449411.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4144","GLP","BK4590"],"gpt_icon":0},{"id":"2538414419","title":"荣耀登顶 | 全球首款申报上市的GCG/GLP-1双受体激动减重降糖药物玛仕度肽的临床研究结果在《新英格兰医学杂志》发布","url":"https://stock-news.laohu8.com/highlight/detail?id=2538414419","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538414419?lang=zh_cn&edition=fundamental","pubTime":"2025-05-26 08:00","pubTimestamp":1748217600,"startTime":"0","endTime":"0","summary":"玛仕度肽预计今年在国内上市，将获批减重降糖两项适应症。此次入选《新英格兰医学杂志》的研究为玛仕度肽一项低剂量减重注册临床研究 GLORY-1。玛仕度肽组整体安全性特征与玛仕度肽的既往研究和其他GLP-1受体激动剂类药物相似。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4695667_ZH95667_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["GLP","BK4144","BK1589","LU1969619763.USD","BK1161","BK4590","BK1583","LU2488822045.USD","LU2328871848.SGD","01801"],"gpt_icon":0},{"id":"2538826111","title":"【众生药业：子公司一类创新药RAY1225注射液两项降糖III期临床试验获伦理批件】众生药业5月25日晚间公告，公司控股子公司广东众生睿创生物科技有限公司自主研发的一类创新多肽药物RAY1225注射液用于2型糖尿病患者的两项III期临床试验获得组长单位北京大学人民医院伦理审查批件，批准项目开展。RAY1225注射液是具有全球自主知识产权的创新结构多肽药物，具有GLP-1受体和GIP受体双重激动活性。","url":"https://stock-news.laohu8.com/highlight/detail?id=2538826111","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538826111?lang=zh_cn&edition=fundamental","pubTime":"2025-05-25 16:15","pubTimestamp":1748160951,"startTime":"0","endTime":"0","summary":"众生药业5月25日晚间公告，公司控股子公司广东众生睿创生物科技有限公司自主研发的一类创新多肽药物RAY1225注射液用于2型糖尿病患者的两项III期临床试验获得组长单位北京大学人民医院伦理审查批件，批准项目开展。RAY1225注射液是具有全球自主知识产权的创新结构多肽药物，具有GLP-1受体和GIP受体双重激动活性。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/25161550649849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1141","BK4134","03347","159837","06978","BK0239","BK1161","BK1574","BK1576","159992","BK4590","GLP","BK0077","BK0188","BK4144","III","BK1583","002317"],"gpt_icon":0},{"id":"2537978648","title":"GLP-1赛道生变：礼来反超，诺和诺德换帅，口服药豪赌胜算几何？","url":"https://stock-news.laohu8.com/highlight/detail?id=2537978648","media":"药事纵横","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537978648?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 06:02","pubTimestamp":1747951341,"startTime":"0","endTime":"0","summary":"5月14日，他们宣布与生物技术公司Septerna达成22亿美元合作，剑指口服小分子减肥药开发。口服药物的开发成为诺和诺德与礼来的共同焦点：诺和诺德计划提交口服版Wegovy的审批，而礼来则探索替尔泊肽的口服制剂。礼来替尔泊肽的GIP/GLP-1双靶点机制已显示出优势，而诺和诺德与Septerna的合作将GLP-1、GIP与胰高血糖素受体纳入研发范围，暗示未来可能推出三靶点药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523061322a488be2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523061322a488be2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2237443622.USD","SGXZ51526630.SGD","LU1061106388.HKD","LU0097036916.USD","LU2750360997.AUD","BK4599","LU0786609619.USD","NVO","SG9999017495.SGD","LU1267930730.SGD","SGXZ99366536.SGD","LU0203202063.USD","LU1988902786.USD","LU0238689110.USD","LU0061475181.USD","IE00BJLML261.HKD","LU1868837300.USD","LU2237443978.SGD","GLP","LU1023059063.AUD","LU0417517546.SGD","IE00BFTCPJ56.SGD","LU1093756168.USD","LU2361044865.SGD","LU0266013472.USD","LU1232071149.USD","LU2471134879.HKD","IE0009355771.USD","BK4533","BK4585","LU2468319806.SGD","LU0354030438.USD","LU0820561818.USD","LU2491050071.SGD","LU1814569148.SGD","IE00BZ1G4Q59.USD","LU0456855351.SGD","SGXZ31699556.SGD","BK4590","LU2552382215.SGD","LLY","LU2324357040.USD","LU2089984988.USD","SG9999001176.USD","LU0708995401.HKD","SG9999015952.SGD","SGXZ57979304.SGD","SG9999018865.SGD","LU0471298777.SGD","BK4144"],"gpt_icon":1},{"id":"2536661051","title":"医药：礼来25Q1收入增长强劲，关注GLP-1药物数据读出","url":"https://stock-news.laohu8.com/highlight/detail?id=2536661051","media":"动脉网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536661051?lang=zh_cn&edition=fundamental","pubTime":"2025-05-20 13:04","pubTimestamp":1747717440,"startTime":"0","endTime":"0","summary":"礼来2025年第一季度财报显示，公司收入增长强劲，总营收127.29亿美元，同比增长45%，主要受益于GLP-1药物替尔泊肽的强劲销售。礼来在美国GLP-1RA市场占据领导地位，占总处方量的53.3%。尽管研发费用和SG&A费用有所增加，非GAAP标准下净利润仍达到30.0亿美元，同比增长29%。此外，CVS Health宣布将Zepbound从报销名单中移除，优先使用诺和诺德的Wegovy，加剧了价格竞争压力。公司在口服GLP-1和siRNA疗法的研发进展顺利，肿瘤管线也进一步拓展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052013062394fc4afb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052013062394fc4afb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLP","LU0320765992.SGD","LU1551013342.USD","LU2602419157.SGD","IE00BJLML261.HKD","LU1069344957.HKD","LU0198837287.USD","IE0009355771.USD","SG9999014914.USD","LU0203202063.USD","LU0289739699.SGD","LU1712237335.SGD","LU1868836757.USD","BK4007","LU2552382215.SGD","SG9999015945.SGD","LU0471298694.HKD","SG9999018865.SGD","LU2264538146.SGD","LU1983299246.USD","LU2750360997.AUD","SG9999013999.USD","SG9999015978.USD","LU1814569148.SGD","LU1035775433.USD","IE00BJJMRZ35.SGD","SG9999018857.SGD","LU0640476718.USD","LLY","LU0943347566.SGD","LU0672654240.SGD","LU0323591593.USD","LU0109394709.USD","LU1623119135.USD","LU2324357040.USD","LU2106854487.HKD","LU2471134796.USD","GB00BDT5M118.USD","LU0820561818.USD","LU2089984988.USD","LU2112291526.USD","LU0316494557.USD","IE0002141913.USD","IE00BK4W5M84.HKD","LU2491049909.HKD","LU1804176565.USD","LU1989771016.USD","LU1551013425.SGD","LU0079474960.USD","LU1061106388.HKD"],"gpt_icon":1},{"id":"2536653353","title":"诺和诺德CEO将卸任，成也GLP-1，败也GLP-1！","url":"https://stock-news.laohu8.com/highlight/detail?id=2536653353","media":"药事纵横","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536653353?lang=zh_cn&edition=fundamental","pubTime":"2025-05-20 06:01","pubTimestamp":1747692117,"startTime":"0","endTime":"0","summary":"5月16日，全球制药巨头诺和诺德发布公告：执掌公司八年的CEO Lars Fruergaard Jrgensen将卸任。成也GLP-1，败也GLP-1，暴露出了诺和诺德过度依赖单一产品的问题。诺和诺德董事会此次打破102年来的本土CEO传统，考虑从外部引入继任者，本质上是对欧洲保守基因的一次颠覆。诺和诺德的换帅风波，恰逢GLP-1市场从爆发期步入整合期的关键节点。截至2023年8月，全球共有106个GLP-1类减肥药进入临床，其中40%来自中国企业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520060329a6e5310a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520060329a6e5310a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","BK4585","LU0154236417.USD","LU1093756325.SGD","BK4590","GLP","IE00BZ1G4Q59.USD","BK4599","BK4144","NVO","BK4588","LU1093756168.USD","BK4007","IE00BKVL7J92.USD"],"gpt_icon":1},{"id":"2536665858","title":"医药行业研究：礼来25Q1收入增长强劲 关注GLP-1药物数据读出","url":"https://stock-news.laohu8.com/highlight/detail?id=2536665858","media":"太平洋证券股份...","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536665858?lang=zh_cn&edition=fundamental","pubTime":"2025-05-20 00:00","pubTimestamp":1747670400,"startTime":"0","endTime":"0","summary":"事件：近日，礼来发布2025 年第一季度财报。核心观点：GLP-1 药物驱动核心业绩，2025Q1 收入增长强劲。礼来2025Q1 总营收127.29 亿美元，同比增长45%，主要受益于替尔泊肽的的强劲销售。2025 年全年收入指引不变，EPS 下调。口服GLP-1、siRNA 疗法研发进展顺利，肿瘤管线进一步拓展。CNS 领域，Donanemab 用于阿尔茨海默病治疗遭欧洲药品监管机构拒绝，有待与监管进一步沟通。2025 年重点关注口服GLP1 和Retatrutide 的减重数据读出。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052011210194fc3858&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052011210194fc3858&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1064131342.USD","BK4581","LU0323591593.USD","LU2063271972.USD","LU0109394709.USD","LU2552382058.USD","SG9999001176.SGD","LLY","LU1868836914.USD","IE00BFTCPJ56.SGD","LU2211815571.USD","IE00B4R5TH58.HKD","LU0882574055.USD","LU2237443549.SGD","LU0203202063.USD","LU2265009873.SGD","LU2552382132.HKD","LU1551013342.USD","LU0238689110.USD","IE00BJT1NW94.SGD","LU0708995401.HKD","LU0316494557.USD","LU0203201768.USD","LU1989771016.USD","BK4590","LU0354030438.USD","LU0061475181.USD","LU0820561909.HKD","LU2361045086.USD","SG9999015986.USD","IE00B2B36J28.USD","LU2491050154.USD","LU0096364046.USD","LU1093756168.USD","LU1057294990.SGD","LU2237443895.HKD","SGXZ81514606.USD","BK4533","SG9999014880.SGD","LU2491050071.SGD","LU2237443978.SGD","LU2237438978.USD","LU0823416689.USD","SG9999015952.SGD","LU1988902786.USD","LU1868836591.USD","LU0471298694.HKD","LU1917777945.USD","GLP","LU0122379950.USD"],"gpt_icon":1},{"id":"2536058299","title":"Global Partners2025财年第一财季实现净利润14.27百万美元，同比增加263.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536058299","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536058299?lang=zh_cn&edition=fundamental","pubTime":"2025-05-18 00:00","pubTimestamp":1747497631,"startTime":"0","endTime":"0","summary":"5月18日，Global Partners公布财报，公告显示公司2025财年第一财季净利润为14.27百万美元，同比增加263.27%；其中营业收入为45.92亿美元，同比增加10.78%，每股基本收益为0.37美元。从资产负债表来看，Global Partners总负债31.23亿美元，其中短期债务3.11亿美元，资产负债比为1.23，流动比率为1.17。机构评级：截至2025年5月18日，当前有1家机构对Global Partners目标价做出预测，其中目标均价为53.00美元，其中最低目标价为53.00美元，最高目标价为53.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000228a6e2d853&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000228a6e2d853&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLP"],"gpt_icon":0},{"id":"2535354468","title":"甘李药业：GZR102注射液Ⅰ期临床试验完成首例受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2535354468","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535354468?lang=zh_cn&edition=fundamental","pubTime":"2025-05-16 16:20","pubTimestamp":1747383605,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["MUCmain","CYB","BK4590","BK1583","603087","BK1576","03347","UCmain","BK0239","CNHmain","MCNHmain","BK1141","GLP","BK4144"],"gpt_icon":0},{"id":"2535330353","title":"港股异动 | 来凯医药-B(02105)午后涨超4% 降脂增肌为下一代GLP-1竞争重点 LAE102受市场关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2535330353","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535330353?lang=zh_cn&edition=fundamental","pubTime":"2025-05-16 13:52","pubTimestamp":1747374747,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，来凯医药-B午后涨超4%，截至发稿，涨3.33%，报14.26港元，成交额1487.17万港元。消息面上，2025年4月，一则来自全球临床试验注册平台ClinicalTrials网站的信息显示，来凯医药更新了其自研管线LAE102针对肥胖症在美国的一项I期临床试验的相关信息。同时，来自ClinicalTrials网站的信息也显示，该研究计划于2025年4月底启动临床入组，预计在2025年8月结束。第一上海指出，降脂增肌将是下一代GLP-1 的竞争重点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1293999.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4590","BK1161","02105","BK4144","GLP"],"gpt_icon":0},{"id":"2534687242","title":"翰宇药业：与碳云智肽签署《GLP-1R/GIPR/GCGR三重激动剂多肽创新药物联合开发协议》","url":"https://stock-news.laohu8.com/highlight/detail?id=2534687242","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534687242?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 18:22","pubTimestamp":1747045360,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0077","BK4144","BK0239","06978","GIPR","BK1161","300199","BK1583","BK0028","GLP","BK4160","BK1574","BK1576","BK0188","BK4590","BK0070","159992","BK1141","03347"],"gpt_icon":0},{"id":"2534266197","title":"替尔泊肽“头对头”完胜司美格鲁肽 千亿GLP-1市场迎“双寡头”时代","url":"https://stock-news.laohu8.com/highlight/detail?id=2534266197","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534266197?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 10:37","pubTimestamp":1747017420,"startTime":"0","endTime":"0","summary":"替尔泊肽组平均减重22.8kg，司美格鲁肽组平均减重15.0kg。另外，在该研究的关键次要终点中，替尔泊肽在所有减重目标中均优于司美格鲁肽。替尔泊肽组实现体重减轻≥15%的参与者比例达64.6%，而司美格鲁肽组为40.1%。此外，替尔泊肽组平均腰围减少达18.4cm，而司美格鲁肽组为13.0cm。该研究的主要目的为证明替尔泊肽相较于司美格鲁肽在第 72 周时，体重自基线降低的百分比的优效性。而目前全球进入III期临床的GLP-1药物中双靶点占比达67%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512104037a6db9cd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512104037a6db9cd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2491050071.SGD","LU0320765059.SGD","SG9999015952.SGD","LU0122379950.USD","SG9999001176.USD","LU1868837136.USD","LU1093756325.SGD","IE0002141913.USD","LU0354030511.USD","LU1988902786.USD","LU1868836914.USD","BK4534","LU0823416689.USD","LU0256863811.USD","SG9999001176.SGD","SGXZ51526630.SGD","LU1127390331.HKD","SGXZ99366536.SGD","LU1974910355.USD","LU2491049909.HKD","SGXZ31699556.SGD","BK4581","SG9999018857.SGD","SG9999014880.SGD","LU2552382058.USD","LU1989771016.USD","LU1917777945.USD","LU1035775433.USD","LU0943347566.SGD","LU0354030438.USD","LU2552382132.HKD","LU0114720955.EUR","LU0238689110.USD","GLP","SGXZ57979304.SGD","LU2237443549.SGD","LU0256863902.USD","SG9999015945.SGD","LU2112291526.USD","LU0323591593.USD","LU1267930730.SGD","LLY","IE00BJT1NW94.SGD","BK4533","LU0203201768.USD","LU0708995401.HKD","LU2468319806.SGD","GB00BDT5M118.USD","LU1868837300.USD","LU0672654240.SGD"],"gpt_icon":1},{"id":"2533136210","title":"美国最大PBM“站队”诺和诺德，礼来大跌10%，GLP-1“双姝”价格战开打！","url":"https://stock-news.laohu8.com/highlight/detail?id=2533136210","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533136210?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 21:49","pubTimestamp":1746712150,"startTime":"0","endTime":"0","summary":"几乎可以预见，未来的“药王”之争或将在诺和诺德和礼来的两大GLP-1单品之间产生。而美国市场无疑是两家公司的决胜关键。","market":"us","thumbnail":"https://wpimg-wscn.awtmt.com/8bd5c21a-ce70-4492-beae-7a87b400e0e1.jpeg","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/8bd5c21a-ce70-4492-beae-7a87b400e0e1.jpeg"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3746724","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3746724","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["GLP","LU1064131342.USD","LU0094547139.USD","LU0385154629.USD","LU1551013342.USD","IE00BJLML261.HKD","LU0114720955.EUR","BK4534","SG9999014914.USD","LU2750360641.GBP","SG9999015986.USD","LU2237443895.HKD","LU0203202063.USD","BK4585","LU0289739699.SGD","IE00B1BXHZ80.USD","LU1712237335.SGD","LU1868836757.USD","LU2237443382.USD","LU2361045086.USD","BK4007","NVO","LU2552382215.SGD","LU0456855351.SGD","LU2023250504.SGD","SG9999014906.USD","LU1093756325.SGD","SG9999015952.SGD","IE00BK4W5L77.USD","LU0266013472.USD","LU2552382132.HKD","BK4599","LLY","LU2471134879.HKD","BK4139","LU1623119135.USD","LU0882574139.USD","LU2106854487.HKD","LU2471134952.CNY","LU1868836591.USD","LU0096364046.USD","LU2112291526.USD","LU2552382058.USD","PBM","LU1804176565.USD","BK4581","LU0471298777.SGD","LU1061106388.HKD","LU1548497426.USD","LU2491050071.SGD"],"gpt_icon":1}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":154,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLP\",params:#limit:5,,,undefined,":[{"date":"2025-05-09","symbol":"GLP","amount":0.745,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-09","defaultRemindTime":1746797400000,"name":"Global Partners Lp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-15","payableDate":"2025-05-09","currency":"USD","dateTimestamp":1746763200000,"payDate":"2025-05-15"},{"market":"US","date":"2025-05-08","symbol":"GLP","fiscalQuarterEnding":"2025/03","expectedEps":-0.03,"name":null,"time":"盘前","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":0.36},{"market":"US","date":"2025-02-28","symbol":"GLP","fiscalQuarterEnding":"2024/12","expectedEps":0.24,"name":null,"time":"盘前","type":"earning","dateTimestamp":1740718800000,"reportTimeType":"pre","actualEps":0.52},{"date":"2025-02-10","symbol":"GLP","amount":0.74,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-10","defaultRemindTime":1739197800000,"name":"全球合伙","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-14","payableDate":"2025-02-10","currency":"USD","dateTimestamp":1739163600000,"payDate":"2025-02-14"},{"date":"2024-11-08","symbol":"GLP","amount":0.73,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-08","defaultRemindTime":1731076200000,"name":"全球合伙","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-11-14","payableDate":"2024-11-08","currency":"USD","dateTimestamp":1731042000000,"payDate":"2024-11-14"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLP\",market:\"US\",,,undefined,":[{"executeDate":"2015-08-03","recordDate":"2015-08-05","paymentDate":"2015-08-14","value":0.6925,"currency":"USD"},{"executeDate":"2015-11-02","recordDate":"2015-11-04","paymentDate":"2015-11-13","value":0.6975,"currency":"USD"},{"executeDate":"2016-02-08","recordDate":"2016-02-10","paymentDate":"2016-02-16","value":0.4625,"currency":"USD"},{"executeDate":"2016-05-04","recordDate":"2016-05-06","paymentDate":"2016-05-16","value":0.4625,"currency":"USD"},{"executeDate":"2016-08-04","recordDate":"2016-08-08","paymentDate":"2016-08-12","value":0.4625,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":2,"updateTime":1741060800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GLP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GLP","date":"2025-06-06","current":15.621074,"percent":0.806736,"low":2.771386,"twenty":4.444767,"median":9.80686,"eighty":15.514776,"high":29.34912,"avg":10.60544,"sd":6.285632,"marketCap":1802031456},"quantilePoints":[{"date":"2020-06-12","current":11.557889,"twenty":6.309309,"median":7.998046,"eighty":11.32112,"marketCap":357369917},{"date":"2020-06-19","current":11.072634,"twenty":6.3117,"median":8.066523,"eighty":11.332667,"marketCap":342365837},{"date":"2020-06-26","current":10.708693,"twenty":6.3117,"median":8.171888,"eighty":11.326893,"marketCap":331112776},{"date":"2020-07-02","current":10.752807,"twenty":6.317715,"median":8.211094,"eighty":11.322275,"marketCap":332476784},{"date":"2020-07-10","current":10.43298,"twenty":6.321861,"median":8.267451,"eighty":11.32112,"marketCap":322587731},{"date":"2020-07-17","current":10.13521,"twenty":6.32825,"median":8.287054,"eighty":11.316433,"marketCap":313380681},{"date":"2020-07-24","current":10.543265,"twenty":6.333279,"median":8.291955,"eighty":11.303569,"marketCap":325997749},{"date":"2020-07-31","current":11.800516,"twenty":6.334178,"median":8.348313,"eighty":11.303569,"marketCap":364871958},{"date":"2020-08-07","current":4.73435,"twenty":6.333279,"median":8.360564,"eighty":11.32112,"marketCap":438154667},{"date":"2020-08-14","current":5.006778,"twenty":6.3117,"median":8.298445,"eighty":11.316433,"marketCap":463367300},{"date":"2020-08-21","current":4.712262,"twenty":6.299659,"median":8.287054,"eighty":11.303569,"marketCap":436110400},{"date":"2020-08-28","current":4.701217,"twenty":6.299607,"median":8.274802,"eighty":11.298552,"marketCap":435088266},{"date":"2020-09-04","current":4.542915,"twenty":6.2824,"median":8.213544,"eighty":11.285346,"marketCap":420437682},{"date":"2020-09-11","current":4.749076,"twenty":6.27606,"median":8.174338,"eighty":11.274368,"marketCap":439517512},{"date":"2020-09-18","current":4.815342,"twenty":6.275736,"median":8.086126,"eighty":11.269162,"marketCap":445650315},{"date":"2020-09-25","current":4.73435,"twenty":6.258044,"median":8.00583,"eighty":11.265698,"marketCap":438154667},{"date":"2020-10-02","current":4.933149,"twenty":6.250305,"median":7.971673,"eighty":11.259925,"marketCap":456553075},{"date":"2020-10-09","current":5.360198,"twenty":6.244429,"median":7.94745,"eighty":11.2525,"marketCap":496075580},{"date":"2020-10-16","current":5.26448,"twenty":6.239772,"median":7.932539,"eighty":11.247278,"marketCap":487217087},{"date":"2020-10-23","current":5.271843,"twenty":6.23717,"median":7.912422,"eighty":11.243223,"marketCap":487898510},{"date":"2020-10-30","current":5.338109,"twenty":6.227089,"median":7.896854,"eighty":11.239367,"marketCap":494031312},{"date":"2020-11-06","current":5.459545,"twenty":6.22179,"median":7.88907,"eighty":11.21862,"marketCap":522855188},{"date":"2020-11-13","current":5.670214,"twenty":6.203808,"median":7.87934,"eighty":11.19873,"marketCap":543030764},{"date":"2020-11-20","current":5.877313,"twenty":6.196135,"median":7.85015,"eighty":11.194013,"marketCap":562864382},{"date":"2020-11-27","current":6.170107,"twenty":6.185826,"median":7.85015,"eighty":11.189536,"marketCap":590905013},{"date":"2020-12-04","current":6.109406,"twenty":6.168749,"median":7.838474,"eighty":11.169685,"marketCap":585091712},{"date":"2020-12-11","current":6.416483,"twenty":6.167844,"median":7.834582,"eighty":11.145422,"marketCap":614500179},{"date":"2020-12-18","current":6.230809,"twenty":6.167844,"median":7.828744,"eighty":11.130907,"marketCap":596718315},{"date":"2020-12-24","current":6.048705,"twenty":6.167844,"median":7.82096,"eighty":11.115597,"marketCap":579278410},{"date":"2020-12-31","current":5.934444,"twenty":6.167844,"median":7.817068,"eighty":11.101741,"marketCap":568335725},{"date":"2021-01-08","current":6.062987,"twenty":6.149862,"median":7.795662,"eighty":11.084422,"marketCap":580646246},{"date":"2021-01-15","current":6.216526,"twenty":6.149862,"median":7.785585,"eighty":11.084422,"marketCap":595350479},{"date":"2021-01-22","current":6.705707,"twenty":6.149862,"median":7.780094,"eighty":11.074992,"marketCap":642198851},{"date":"2021-01-29","current":7.180605,"twenty":6.149862,"median":7.776202,"eighty":11.068208,"marketCap":687679388},{"date":"2021-02-05","current":7.284155,"twenty":6.149862,"median":7.768418,"eighty":11.06411,"marketCap":697596196},{"date":"2021-02-12","current":6.934229,"twenty":6.163202,"median":7.760634,"eighty":11.053134,"marketCap":664084222},{"date":"2021-02-19","current":7.112763,"twenty":6.167321,"median":7.75285,"eighty":11.04396,"marketCap":681182168},{"date":"2021-02-26","current":7.202029,"twenty":6.167844,"median":7.741174,"eighty":11.038761,"marketCap":689731141},{"date":"2021-03-05","current":6.896217,"twenty":6.167844,"median":7.718575,"eighty":11.032407,"marketCap":695214499},{"date":"2021-03-12","current":7.842623,"twenty":6.167844,"median":7.698362,"eighty":11.017031,"marketCap":790622686},{"date":"2021-03-19","current":7.720506,"twenty":6.167844,"median":7.718575,"eighty":11.007626,"marketCap":778311953},{"date":"2021-03-26","current":7.411822,"twenty":6.167844,"median":7.69367,"eighty":11.00501,"marketCap":747193153},{"date":"2021-04-01","current":7.320234,"twenty":6.167844,"median":7.686686,"eighty":10.988222,"marketCap":737960103},{"date":"2021-04-09","current":7.3779,"twenty":6.167844,"median":7.67501,"eighty":10.954813,"marketCap":743773505},{"date":"2021-04-16","current":7.510194,"twenty":6.168749,"median":7.659442,"eighty":10.940212,"marketCap":757110133},{"date":"2021-04-23","current":7.364332,"twenty":6.170107,"median":7.594997,"eighty":10.930856,"marketCap":742405645},{"date":"2021-04-30","current":8.185229,"twenty":6.171613,"median":7.641929,"eighty":10.912383,"marketCap":825161134},{"date":"2021-05-07","current":9.181725,"twenty":6.178654,"median":7.67501,"eighty":10.905455,"marketCap":849502414},{"date":"2021-05-14","current":8.749253,"twenty":6.185826,"median":7.686686,"eighty":10.905455,"marketCap":809489619},{"date":"2021-05-21","current":9.203903,"twenty":6.185826,"median":7.690578,"eighty":10.897433,"marketCap":851554353},{"date":"2021-05-28","current":9.407203,"twenty":6.185826,"median":7.712361,"eighty":10.877257,"marketCap":870363786},{"date":"2021-06-04","current":9.706607,"twenty":6.189262,"median":7.720506,"eighty":10.864653,"marketCap":898064952},{"date":"2021-06-11","current":10.061456,"twenty":6.203126,"median":7.741174,"eighty":10.858681,"marketCap":930895963},{"date":"2021-06-18","current":9.603109,"twenty":6.203644,"median":7.748958,"eighty":10.836624,"marketCap":888489240},{"date":"2021-06-25","current":9.680732,"twenty":6.203808,"median":7.760634,"eighty":10.817799,"marketCap":895671024},{"date":"2021-07-02","current":9.658554,"twenty":6.203808,"median":7.768418,"eighty":10.809851,"marketCap":893619086},{"date":"2021-07-09","current":9.31849,"twenty":6.203808,"median":7.778148,"eighty":10.796921,"marketCap":862156033},{"date":"2021-07-16","current":8.963641,"twenty":6.213362,"median":7.780094,"eighty":10.785892,"marketCap":829325022},{"date":"2021-07-23","current":9.495915,"twenty":6.213362,"median":7.785616,"eighty":10.763835,"marketCap":878571539},{"date":"2021-07-30","current":9.909906,"twenty":6.216526,"median":7.795662,"eighty":10.752807,"marketCap":916874385},{"date":"2021-08-06","current":29.34912,"twenty":6.22179,"median":7.817068,"eighty":10.752807,"marketCap":823536295},{"date":"2021-08-13","current":26.023372,"twenty":6.22179,"median":7.822906,"eighty":10.813084,"marketCap":730215805},{"date":"2021-08-20","current":24.554702,"twenty":6.22179,"median":7.83069,"eighty":10.865043,"marketCap":689004931},{"date":"2021-08-27","current":24.530426,"twenty":6.22179,"median":7.834582,"eighty":10.905455,"marketCap":688323760},{"date":"2021-09-03","current":25.100901,"twenty":6.22179,"median":7.842494,"eighty":10.964493,"marketCap":704331289},{"date":"2021-09-10","current":24.275533,"twenty":6.228856,"median":7.848204,"eighty":11.013201,"marketCap":681171460},{"date":"2021-09-17","current":25.198003,"twenty":6.230622,"median":7.85015,"eighty":11.053134,"marketCap":707055975},{"date":"2021-09-24","current":24.894559,"twenty":6.230772,"median":7.876969,"eighty":11.084422,"marketCap":698541332},{"date":"2021-10-01","current":26.047647,"twenty":6.233421,"median":7.883329,"eighty":11.141011,"marketCap":730896976},{"date":"2021-10-08","current":26.897291,"twenty":6.234318,"median":7.892962,"eighty":11.19642,"marketCap":754737977},{"date":"2021-10-15","current":26.836602,"twenty":6.236185,"median":7.896854,"eighty":11.246674,"marketCap":753035049},{"date":"2021-10-22","current":28.632991,"twenty":6.237348,"median":7.914368,"eighty":11.269162,"marketCap":803441737},{"date":"2021-10-29","current":28.329547,"twenty":6.237865,"median":7.935774,"eighty":11.303569,"marketCap":794927093},{"date":"2021-11-05","current":18.151279,"twenty":6.239408,"median":7.94745,"eighty":11.328048,"marketCap":776838422},{"date":"2021-11-12","current":18.191189,"twenty":6.239772,"median":7.988112,"eighty":11.346522,"marketCap":778546510},{"date":"2021-11-19","current":18.773882,"twenty":6.239772,"median":8.014118,"eighty":11.360961,"marketCap":803484595},{"date":"2021-11-26","current":18.694061,"twenty":6.239772,"median":8.035981,"eighty":11.378852,"marketCap":800068419},{"date":"2021-12-03","current":18.103386,"twenty":6.239772,"median":8.105729,"eighty":11.403489,"marketCap":774788716},{"date":"2021-12-10","current":18.430652,"twenty":6.240495,"median":8.179783,"eighty":11.427136,"marketCap":788795038},{"date":"2021-12-17","current":18.550383,"twenty":6.243048,"median":8.213544,"eighty":11.470285,"marketCap":793919302},{"date":"2021-12-23","current":17.991637,"twenty":6.244429,"median":8.252749,"eighty":11.474686,"marketCap":770006070},{"date":"2021-12-31","current":18.749936,"twenty":6.244429,"median":8.284603,"eighty":11.575574,"marketCap":802459742},{"date":"2022-01-07","current":20.051017,"twenty":6.24581,"median":8.291955,"eighty":11.616705,"marketCap":858143411},{"date":"2022-01-14","current":21.152545,"twenty":6.248234,"median":8.320498,"eighty":11.690231,"marketCap":905286640},{"date":"2022-01-21","current":20.146802,"twenty":6.249277,"median":8.363015,"eighty":11.729858,"marketCap":862242822},{"date":"2022-01-28","current":21.392008,"twenty":6.251718,"median":8.365465,"eighty":11.776801,"marketCap":915535168},{"date":"2022-02-04","current":21.85497,"twenty":6.254157,"median":8.433466,"eighty":11.837284,"marketCap":935348988},{"date":"2022-02-11","current":21.559632,"twenty":6.257754,"median":8.47328,"eighty":11.938846,"marketCap":922709137},{"date":"2022-02-18","current":20.945011,"twenty":6.257851,"median":8.48054,"eighty":12.432666,"marketCap":896404582},{"date":"2022-02-25","current":20.529942,"twenty":6.258237,"median":8.487891,"eighty":12.775373,"marketCap":878640467},{"date":"2022-03-04","current":15.348683,"twenty":6.268592,"median":8.571294,"eighty":13.121553,"marketCap":878174885},{"date":"2022-03-11","current":15.504022,"twenty":6.275496,"median":8.601399,"eighty":13.154839,"marketCap":887062603},{"date":"2022-03-18","current":15.940166,"twenty":6.275736,"median":8.649704,"eighty":13.201441,"marketCap":912016580},{"date":"2022-03-25","current":16.890123,"twenty":6.275736,"median":8.669307,"eighty":13.248042,"marketCap":966368393},{"date":"2022-04-01","current":16.214996,"twenty":6.275736,"median":8.68891,"eighty":13.261356,"marketCap":927741004},{"date":"2022-04-08","current":16.752708,"twenty":6.275736,"median":8.726599,"eighty":13.281328,"marketCap":958506181},{"date":"2022-04-14","current":16.573471,"twenty":6.275736,"median":8.736337,"eighty":13.3013,"marketCap":948251122},{"date":"2022-04-22","current":16.011861,"twenty":6.276168,"median":8.777122,"eighty":13.329261,"marketCap":916118604},{"date":"2022-04-29","current":15.743005,"twenty":6.281175,"median":8.797306,"eighty":13.342575,"marketCap":900736015},{"date":"2022-05-06","current":9.804164,"twenty":6.2824,"median":8.848712,"eighty":13.349233,"marketCap":897659497},{"date":"2022-05-13","current":9.69216,"twenty":6.2824,"median":8.9103,"eighty":13.347901,"marketCap":887404438},{"date":"2022-05-20","current":10.270852,"twenty":6.291454,"median":8.930374,"eighty":13.347901,"marketCap":940388910},{"date":"2022-05-27","current":11.163158,"twenty":6.293718,"median":8.972794,"eighty":13.342575,"marketCap":1022087547},{"date":"2022-06-03","current":10.868211,"twenty":6.294536,"median":8.995202,"eighty":13.341244,"marketCap":995082558},{"date":"2022-06-10","current":10.244717,"twenty":6.297672,"median":9.026396,"eighty":13.341244,"marketCap":937996063},{"date":"2022-06-17","current":7.754474,"twenty":6.299555,"median":9.016925,"eighty":13.33725,"marketCap":709991918},{"date":"2022-06-24","current":8.613179,"twenty":6.299659,"median":8.99034,"eighty":13.331924,"marketCap":788614037},{"date":"2022-07-01","current":8.814788,"twenty":6.299659,"median":8.977241,"eighty":13.322603,"marketCap":807073143},{"date":"2022-07-08","current":8.900658,"twenty":6.299659,"median":8.963641,"eighty":13.313284,"marketCap":814935355},{"date":"2022-07-15","current":8.867057,"twenty":6.299659,"median":8.92485,"eighty":13.306626,"marketCap":811858837},{"date":"2022-07-22","current":9.561487,"twenty":6.300172,"median":8.963641,"eighty":13.3013,"marketCap":875440203},{"date":"2022-07-29","current":10.371656,"twenty":6.303369,"median":8.980096,"eighty":13.299969,"marketCap":949618463},{"date":"2022-08-05","current":3.850073,"twenty":6.303369,"median":8.997729,"eighty":13.29198,"marketCap":927520968},{"date":"2022-08-12","current":4.016293,"twenty":6.299659,"median":8.972794,"eighty":13.281328,"marketCap":967565231},{"date":"2022-08-19","current":3.999245,"twenty":6.293991,"median":8.937993,"eighty":13.278687,"marketCap":963458127},{"date":"2022-08-26","current":3.899797,"twenty":6.2824,"median":8.919306,"eighty":13.268103,"marketCap":939500021},{"date":"2022-09-02","current":4.077383,"twenty":6.275736,"median":8.9103,"eighty":13.268014,"marketCap":982282354},{"date":"2022-09-09","current":4.169728,"twenty":6.275496,"median":8.900658,"eighty":13.268014,"marketCap":1004529167},{"date":"2022-09-16","current":4.014873,"twenty":6.257754,"median":8.857885,"eighty":13.261356,"marketCap":967222973},{"date":"2022-09-23","current":3.607134,"twenty":6.247881,"median":8.814788,"eighty":13.254699,"marketCap":868994737},{"date":"2022-09-30","current":3.51621,"twenty":6.240977,"median":8.791187,"eighty":13.254699,"marketCap":847090183},{"date":"2022-10-07","current":3.916845,"twenty":6.239772,"median":8.777122,"eighty":13.248042,"marketCap":943607125},{"date":"2022-10-14","current":3.740679,"twenty":6.236636,"median":8.755886,"eighty":13.248042,"marketCap":901167051},{"date":"2022-10-21","current":4.087328,"twenty":6.230622,"median":8.734756,"eighty":13.241384,"marketCap":984678164},{"date":"2022-10-28","current":4.250707,"twenty":6.22179,"median":8.716798,"eighty":13.234727,"marketCap":1024037910},{"date":"2022-11-04","current":3.449288,"twenty":6.213362,"median":8.68891,"eighty":13.208098,"marketCap":1095762902},{"date":"2022-11-11","current":3.301892,"twenty":6.203808,"median":8.669307,"eighty":13.201441,"marketCap":1048938349},{"date":"2022-11-18","current":3.311575,"twenty":6.185826,"median":8.649704,"eighty":13.194783,"marketCap":1052014414},{"date":"2022-11-25","current":3.399797,"twenty":6.17312,"median":8.639313,"eighty":13.17348,"marketCap":1080040789},{"date":"2022-12-02","current":3.385811,"twenty":6.167844,"median":8.62969,"eighty":13.162828,"marketCap":1075597583},{"date":"2022-12-09","current":3.518145,"twenty":6.167844,"median":8.601399,"eighty":13.156171,"marketCap":1117637146},{"date":"2022-12-16","current":3.574091,"twenty":6.149862,"median":8.577106,"eighty":13.154839,"marketCap":1135409969},{"date":"2022-12-23","current":3.865656,"twenty":6.146266,"median":8.549709,"eighty":13.144188,"marketCap":1228033720},{"date":"2022-12-30","current":3.740853,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1188386653},{"date":"2023-01-06","current":3.441757,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1093370406},{"date":"2023-01-13","current":3.612823,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1147714231},{"date":"2023-01-20","current":3.620354,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1150106726},{"date":"2023-01-27","current":3.857048,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1225299440},{"date":"2023-02-03","current":4.130323,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1312112845},{"date":"2023-02-10","current":3.93774,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1250933319},{"date":"2023-02-17","current":3.875339,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1231109786},{"date":"2023-02-24","current":3.718259,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1181209167},{"date":"2023-03-03","current":3.363192,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1194165378},{"date":"2023-03-10","current":3.211151,"twenty":6.113691,"median":8.482899,"eighty":13.133536,"marketCap":1140180220},{"date":"2023-03-17","current":2.830086,"twenty":6.097582,"median":8.463126,"eighty":13.133536,"marketCap":1004875645},{"date":"2023-03-24","current":2.875313,"twenty":6.070129,"median":8.365465,"eighty":13.133536,"marketCap":1020934521},{"date":"2023-03-31","current":2.985014,"twenty":6.034422,"median":8.291955,"eighty":13.130873,"marketCap":1059885838},{"date":"2023-04-06","current":2.892634,"twenty":6.016569,"median":8.274802,"eighty":13.130873,"marketCap":1027084729},{"date":"2023-04-14","current":2.896483,"twenty":5.960153,"median":8.185229,"eighty":13.133536,"marketCap":1028451442},{"date":"2023-04-20","current":2.925352,"twenty":5.879004,"median":8.105729,"eighty":13.133536,"marketCap":1038701788},{"date":"2023-04-28","current":2.932088,"twenty":5.726233,"median":7.998046,"eighty":13.136199,"marketCap":1041093536},{"date":"2023-05-05","current":2.771386,"twenty":5.536171,"median":7.943558,"eighty":13.136199,"marketCap":984033273},{"date":"2023-05-12","current":2.975648,"twenty":5.442294,"median":7.932539,"eighty":13.136199,"marketCap":1050433502},{"date":"2023-05-19","current":3.089052,"twenty":5.341054,"median":7.932539,"eighty":13.136199,"marketCap":1090466310},{"date":"2023-05-26","current":2.874844,"twenty":5.253436,"median":7.932539,"eighty":13.136199,"marketCap":1014848784},{"date":"2023-06-02","current":2.846736,"twenty":5.130475,"median":7.932539,"eighty":13.136199,"marketCap":1004926122},{"date":"2023-06-09","current":3.07839,"twenty":5.004569,"median":7.932539,"eighty":13.136199,"marketCap":1086702542},{"date":"2023-06-16","current":3.058036,"twenty":4.918423,"median":7.932539,"eighty":13.136199,"marketCap":1079517166},{"date":"2023-06-23","current":2.916523,"twenty":4.864674,"median":7.935774,"eighty":13.138862,"marketCap":1029561696},{"date":"2023-06-30","current":2.952386,"twenty":4.815342,"median":7.93772,"eighty":13.141525,"marketCap":1042221644},{"date":"2023-07-07","current":2.944631,"twenty":4.771165,"median":7.93772,"eighty":13.141525,"marketCap":1039484358},{"date":"2023-07-14","current":3.066759,"twenty":4.749076,"median":7.93772,"eighty":13.141525,"marketCap":1082596613},{"date":"2023-07-21","current":3.116192,"twenty":4.697536,"median":7.93772,"eighty":13.141525,"marketCap":1100046811},{"date":"2023-07-28","current":3.215057,"twenty":4.671766,"median":7.93772,"eighty":13.141525,"marketCap":1134947207},{"date":"2023-08-04","current":3.279998,"twenty":4.616544,"median":7.93772,"eighty":13.141525,"marketCap":1157871978},{"date":"2023-08-11","current":4.645552,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075069076},{"date":"2023-08-18","current":4.647031,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075411237},{"date":"2023-08-25","current":4.663295,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1079175005},{"date":"2023-09-01","current":4.624853,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1070278826},{"date":"2023-09-08","current":4.647031,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075411237},{"date":"2023-09-15","current":4.775663,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1105179222},{"date":"2023-09-22","current":4.867332,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1126393189},{"date":"2023-09-29","current":5.173389,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1197220464},{"date":"2023-10-06","current":4.475521,"twenty":4.542915,"median":7.93772,"eighty":13.141525,"marketCap":1035720590},{"date":"2023-10-13","current":4.511006,"twenty":4.484012,"median":7.93772,"eighty":13.141525,"marketCap":1043932448},{"date":"2023-10-20","current":4.482914,"twenty":4.482914,"median":7.93772,"eighty":13.141525,"marketCap":1037431394},{"date":"2023-10-27","current":4.534662,"twenty":4.467537,"median":7.94745,"eighty":13.149513,"marketCap":1049407020},{"date":"2023-11-03","current":4.904296,"twenty":4.458666,"median":7.94745,"eighty":13.149513,"marketCap":1134947207},{"date":"2023-11-10","current":7.439549,"twenty":4.458666,"median":7.935774,"eighty":13.149513,"marketCap":1088071185},{"date":"2023-11-17","current":7.820894,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1143844827},{"date":"2023-11-24","current":7.993518,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1169092039},{"date":"2023-12-01","current":8.460278,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1237357955},{"date":"2023-12-08","current":8.743603,"twenty":4.459848,"median":7.902692,"eighty":13.146851,"marketCap":1278795691},{"date":"2023-12-15","current":8.690189,"twenty":4.459848,"median":7.902692,"eighty":13.146851,"marketCap":1270983658},{"date":"2023-12-22","current":9.616802,"twenty":4.459848,"median":7.934448,"eighty":13.146851,"marketCap":1406505433},{"date":"2023-12-29","current":9.686473,"twenty":4.4563,"median":7.940074,"eighty":13.154839,"marketCap":1416695040},{"date":"2024-01-05","current":9.75382,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1426544994},{"date":"2024-01-12","current":9.809556,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1434696679},{"date":"2024-01-19","current":10.16023,"twenty":4.448612,"median":7.939666,"eighty":13.154839,"marketCap":1485984368},{"date":"2024-01-26","current":10.740814,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1570897761},{"date":"2024-02-02","current":10.601474,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1550518547},{"date":"2024-02-09","current":10.963759,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1603504503},{"date":"2024-02-16","current":11.124,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1626940600},{"date":"2024-02-23","current":10.647921,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1557311618},{"date":"2024-03-01","current":11.10678,"twenty":4.4563,"median":7.940074,"eighty":13.154839,"marketCap":1583804596},{"date":"2024-03-08","current":11.32675,"twenty":4.4563,"median":7.94745,"eighty":13.154839,"marketCap":1615171958},{"date":"2024-03-15","current":10.799262,"twenty":4.4563,"median":7.990262,"eighty":13.154839,"marketCap":1539953125},{"date":"2024-03-22","current":11.659401,"twenty":4.4563,"median":8.049544,"eighty":13.154839,"marketCap":1662607257},{"date":"2024-03-28","current":10.571159,"twenty":4.4563,"median":8.239503,"eighty":13.154839,"marketCap":1507426062},{"date":"2024-04-05","current":10.811142,"twenty":4.452456,"median":8.461702,"eighty":13.154839,"marketCap":1541647243},{"date":"2024-04-12","current":11.186562,"twenty":4.452456,"median":8.566313,"eighty":13.154839,"marketCap":1595181367},{"date":"2024-04-19","current":10.81827,"twenty":4.452456,"median":8.624771,"eighty":13.154839,"marketCap":1542663714},{"date":"2024-04-26","current":11.245964,"twenty":4.4563,"median":8.639313,"eighty":13.154839,"marketCap":1603651956},{"date":"2024-05-03","current":11.324374,"twenty":4.4563,"median":8.690189,"eighty":13.154839,"marketCap":1614833134},{"date":"2024-05-10","current":14.682959,"twenty":4.4563,"median":8.734756,"eighty":13.168154,"marketCap":1565364893},{"date":"2024-05-17","current":13.78037,"twenty":4.4563,"median":8.734756,"eighty":13.224197,"marketCap":1469138999},{"date":"2024-05-24","current":14.166489,"twenty":4.4563,"median":8.734756,"eighty":13.241384,"marketCap":1510303519},{"date":"2024-05-31","current":15.403069,"twenty":4.4563,"median":8.734756,"eighty":13.248042,"marketCap":1642136538},{"date":"2024-06-07","current":15.399881,"twenty":4.4563,"median":8.734756,"eighty":13.254699,"marketCap":1641796762},{"date":"2024-06-14","current":15.042931,"twenty":4.4563,"median":8.734756,"eighty":13.254699,"marketCap":1603741870},{"date":"2024-06-21","current":14.389583,"twenty":4.452456,"median":8.72747,"eighty":13.257384,"marketCap":1534087827},{"date":"2024-06-28","current":14.542562,"twenty":4.452456,"median":8.72747,"eighty":13.270766,"marketCap":1550397066},{"date":"2024-07-05","current":14.395957,"twenty":4.452456,"median":8.72747,"eighty":13.285322,"marketCap":1534767378},{"date":"2024-07-12","current":13.586443,"twenty":4.452456,"median":8.72747,"eighty":13.285322,"marketCap":1448464320},{"date":"2024-07-19","current":12.767369,"twenty":4.452456,"median":8.72747,"eighty":13.228966,"marketCap":1361141934},{"date":"2024-07-26","current":12.910786,"twenty":4.452456,"median":8.72747,"eighty":13.052045,"marketCap":1376431846},{"date":"2024-08-02","current":13.302795,"twenty":4.452456,"median":8.72747,"eighty":12.924809,"marketCap":1418224272},{"date":"2024-08-09","current":12.449802,"twenty":4.452456,"median":8.72747,"eighty":12.75462,"marketCap":1335540014},{"date":"2024-08-16","current":13.196601,"twenty":4.452456,"median":8.72747,"eighty":12.789678,"marketCap":1415652134},{"date":"2024-08-23","current":13.473893,"twenty":4.452456,"median":8.72747,"eighty":13.02799,"marketCap":1445398406},{"date":"2024-08-30","current":14.204937,"twenty":4.452456,"median":8.72747,"eighty":13.191559,"marketCap":1523820396},{"date":"2024-09-06","current":13.316341,"twenty":4.452456,"median":8.72747,"eighty":13.222287,"marketCap":1428497115},{"date":"2024-09-13","current":13.558971,"twenty":4.452456,"median":8.72747,"eighty":13.305504,"marketCap":1454525103},{"date":"2024-09-20","current":14.226994,"twenty":4.452456,"median":8.72747,"eighty":13.395117,"marketCap":1526186577},{"date":"2024-09-27","current":14.085197,"twenty":4.452456,"median":8.72747,"eighty":13.544476,"marketCap":1510975415},{"date":"2024-10-04","current":14.976944,"twenty":4.452456,"median":8.72747,"eighty":13.679972,"marketCap":1606636722},{"date":"2024-10-11","current":14.803637,"twenty":4.452456,"median":8.72747,"eighty":13.85562,"marketCap":1588045302},{"date":"2024-10-18","current":14.529495,"twenty":4.452456,"median":8.72747,"eighty":14.019655,"marketCap":1558637056},{"date":"2024-10-25","current":14.772126,"twenty":4.452456,"median":8.72747,"eighty":14.168401,"marketCap":1584665044},{"date":"2024-11-01","current":14.778428,"twenty":4.452456,"median":8.72747,"eighty":14.27768,"marketCap":1585341095},{"date":"2024-11-08","current":13.141823,"twenty":4.452456,"median":8.73918,"eighty":14.377354,"marketCap":1640493731},{"date":"2024-11-15","current":13.379586,"twenty":4.452456,"median":8.78252,"eighty":14.377354,"marketCap":1670173717},{"date":"2024-11-22","current":14.322533,"twenty":4.452456,"median":8.81344,"eighty":14.377354,"marketCap":1787881840},{"date":"2024-11-29","current":15.251971,"twenty":4.452456,"median":8.883858,"eighty":14.399781,"marketCap":1903903601},{"date":"2024-12-06","current":15.273586,"twenty":4.452456,"median":8.934183,"eighty":14.482822,"marketCap":1906601781},{"date":"2024-12-13","current":14.4198,"twenty":4.452456,"median":9.012663,"eighty":14.537463,"marketCap":1800023652},{"date":"2024-12-20","current":12.93378,"twenty":4.452456,"median":9.090449,"eighty":14.537463,"marketCap":1614523744},{"date":"2024-12-27","current":12.995923,"twenty":4.452456,"median":9.19602,"eighty":14.537463,"marketCap":1622281013},{"date":"2025-01-03","current":12.766265,"twenty":4.452456,"median":9.268408,"eighty":14.537463,"marketCap":1593612846},{"date":"2025-01-10","current":12.631172,"twenty":4.448612,"median":9.31881,"eighty":14.538738,"marketCap":1576749218},{"date":"2025-01-17","current":14.282006,"twenty":4.448612,"median":9.382279,"eighty":14.538738,"marketCap":1782822752},{"date":"2025-01-24","current":13.892938,"twenty":4.448612,"median":9.455255,"eighty":14.538738,"marketCap":1734255503},{"date":"2025-01-31","current":14.63865,"twenty":4.448612,"median":9.481129,"eighty":14.558635,"marketCap":1827342730},{"date":"2025-02-07","current":15.684268,"twenty":4.448612,"median":9.514397,"eighty":14.63454,"marketCap":1957867210},{"date":"2025-02-14","current":15.462716,"twenty":4.448612,"median":9.568033,"eighty":14.675959,"marketCap":1930210860},{"date":"2025-02-21","current":15.732902,"twenty":4.448612,"median":9.580931,"eighty":14.694621,"marketCap":1963938116},{"date":"2025-02-28","current":20.937616,"twenty":4.448612,"median":9.626092,"eighty":14.774647,"marketCap":1933567942},{"date":"2025-03-07","current":19.49754,"twenty":4.444767,"median":9.675026,"eighty":14.838928,"marketCap":1800578330},{"date":"2025-03-14","current":19.960552,"twenty":4.444767,"median":9.675026,"eighty":14.901539,"marketCap":1843337016},{"date":"2025-03-21","current":19.362647,"twenty":4.444767,"median":9.689317,"eighty":15.017908,"marketCap":1788121076},{"date":"2025-03-28","current":19.698057,"twenty":4.444767,"median":9.708699,"eighty":15.110765,"marketCap":1819095871},{"date":"2025-04-04","current":17.87153,"twenty":4.444767,"median":9.75606,"eighty":15.125044,"marketCap":1650417909},{"date":"2025-04-11","current":17.576223,"twenty":4.448612,"median":9.799015,"eighty":15.243459,"marketCap":1623146621},{"date":"2025-04-17","current":18.509538,"twenty":4.448612,"median":9.802712,"eighty":15.283315,"marketCap":1709337357},{"date":"2025-04-25","current":18.910572,"twenty":4.444767,"median":9.80686,"eighty":15.360398,"marketCap":1746372438},{"date":"2025-05-02","current":18.710055,"twenty":4.444767,"median":9.80686,"eighty":15.401794,"marketCap":1727854897},{"date":"2025-05-09","current":14.05872,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1621799891},{"date":"2025-05-16","current":14.406029,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1661865116},{"date":"2025-05-23","current":14.373925,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1658161608},{"date":"2025-05-30","current":15.450609,"twenty":4.444767,"median":9.80686,"eighty":15.444645,"marketCap":1782366767},{"date":"2025-06-06","current":15.621074,"twenty":4.444767,"median":9.80686,"eighty":15.514776,"marketCap":1802031456}],"updateTime":1749400676888}}}